UAEM - Licensing and patenting practices of UK research institutions 2019-2020

Sarai Keestra made this Freedom of Information request to University of Exeter

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

The request was successful.

Dear University of Exeter,

We have previously sent FOI requests asking for information about the licensing practices of UK universities. This was concerning the time period 18th October 2018 to 18th October 2019. We are now looking to update the information for the following year, 19th October 2019 to 19th October 2020.

The updated request is listed below:

For the purpose of clarity, please adhere to the following definitions when answering these questions:

Definitions
Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/y5dwc2qv]

A patent grants an inventor the exclusive rights to his or her invention. A patent holder can stop other people from selling, manufacturing, producing, or using the invention for a certain period of time.
Source: Upcouncil, available online [https://www.upcounsel.com/what-is-a-pate...

Licence: Permission for the licensee to use the intellectual property rights
Source: TaylorWessing, available online [https://www.taylorwessing.com/download/a...

Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.
Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://www.taylorwessing.com/synapse/co...

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’
Source: WHO, available online [https://www.who.int/health-technology-as...

START FOI request:
Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the period 19th October 2019 to 19th October 2020 AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q3. Please provide a list of patents granted to your organization in the period 19th October 2019 to 19th October 2020, listed by patent family, indicating countries/regions in which the patent has been granted.

Q4. In the period 19th October 2019 to 19th October 2020, has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?

❏ Contributed sample clauses to the AUTM Global Health Toolkit
❏ Published an article, guidance, or other literature on access licensing practices
❏ Formally presented on access licensing practices at an academic or professional event, or at another university
❏ Informally shared or discussed access licensing practices with administrators at other universities
❏ Other
❏ None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the period 19th October 2019 to 19th October 2020 to improve access to the technologies they license in low-and middle-income settings?

END FOI request.
If you have any questions please do not hesitate to contact me by email.

Yours faithfully,

Sarai Keestra

InformationGovernance mailbox, University of Exeter

Dear Sarai,

Thank you for your request under the information Act of 2000. Your reference number is FOI20-448.

Due to the exceptional circumstances caused by current global events there may be some delay in responding to your information request. Following the guidance from the ICO the Information Governance Team continue to work to the timelines set out in law however while the University transitions to new working practices there may be some delays to the responses we receive from data owners and other colleagues across the organisation.

To avoid any of these delays we would urge you to check public data sources including the University website, HESA, UCAS and the Research Councils. Please also ensure that your request is clearly stated so that we can ensure we are directing requests to the most appropriate areas of the business.

The data you provide to allow us to process your request is collected so that you are able to exercise your lawful rights under the Freedom of Information Act. Your personal data will be held by the Information Governance Office and shared with relevant staff as necessary.

Once a request has been completed, the relevant data will be held by the Information Governance Office for three years in line with ICO guidance, this is to ensure the University has fully carried out its requirements under the legislation.

For further information on how we process your personal data, please see: http://www.exeter.ac.uk/dataprotection/

The University should respond to your FOI request as soon as possible and no later than twenty working days after the date of receipt of the request. Should The University be required to undertake a public interest test relating to the potential application of a qualified exemption we may extend the time frame by up to twenty additional days. Please be aware that our response time takes into account the workloads of the Information Governance Office and relevant data owners and will therefore not always correlate with the complexity of the request. Should The University seek clarification any resulting time spent awaiting communication will not be counted against that time limit.

Regards,

Information Governance Officer

University of Exeter
www.exeter.ac.uk
Lafrowda House, St. German’s Road, Exeter, EX4 6TL

This email and any attachment may contain information that is confidential, privileged, or subject to copyright, and which may be exempt from disclosure under applicable legislation. It is intended for the addressee only. If you received this message in error, please let me know and delete the email and any attachments immediately. The University will not accept responsibility for the accuracy/completeness of this email and its attachments.

show quoted sections

InformationGovernance mailbox, University of Exeter

3 Attachments

Dear Sarai,

 

Please find the University's response to your Freedom of Information
Request attached.

 

Kind regards,

 

Information Governance Officer

University of Exeter 
http://www.exeter.ac.uk/foi/summary/
Lafrowda House, St. German’s Road, Exeter, EX4 6TL

[1]cid:b66e35d4-2ef1-4fbc-b54c-e0bdf7daabe1

This email and any attachment may contain information that is
confidential, privileged, or subject to copyright, and which may be exempt
from disclosure under applicable legislation. It is intended for the
addressee only. If you received this message in error, please let me know
and delete the email and any attachments immediately. The University will
not accept responsibility for the accuracy/completeness of this email and
its attachments.

 

 

------------------------------------------------------------------------

From: Sarai Keestra <[FOI #703582 email]>
Sent: 04 November 2020 08:39
To: InformationGovernance mailbox <[email address]>
Subject: Freedom of Information request - UAEM - Licensing and patenting
practices of UK research institutions 2019-2020

 

CAUTION: This email originated from outside of the organisation. Do not
click links or open attachments unless you recognise the sender and know
the content is safe.

Dear University of Exeter,

We have previously sent FOI requests asking for information about the
licensing practices of UK universities. This was concerning the time
period 18th October 2018 to 18th October 2019. We are now looking to
update the information for the following year, 19th October 2019 to 19th
October 2020.

The updated request is listed below:

For the purpose of clarity, please adhere to the following definitions
when answering these questions:

Definitions

Low and middle income country: A country that is defined as ‘low’,
‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year
2018. Income status defined by GNI per capita.

Source: World bank, available online
[[2]https://eur03.safelinks.protection.outlo...

A patent grants an inventor the exclusive rights to his or her invention.
A patent holder can stop other people from selling, manufacturing,
producing, or using the invention for a certain period of time.

Source: Upcouncil, available online
[[3]https://eur03.safelinks.protection.outlo...

Licence: Permission for the licensee to use the intellectual property
rights

Source: TaylorWessing, available online
[[4]https://eur03.safelinks.protection.outlo...

Exclusive Licence: A licence that allows only the named licensee to
exploit the relevant IP rights, the licensor is also excluded from
exploiting these IP rights.

Non-Exclusive Licence: A licence that grants any number of licensees to
exploit the IP.

Source: TaylorWessing, available online
[[5]https://eur03.safelinks.protection.outlo...

Health Technology: ‘Health technology as defined by the WHO: “A health
technology is the application of organized knowledge and skills in the
form of devices, medicines, vaccines, procedures and systems developed to
solve a health problem and improve quality of lives.’

Source: WHO, available online
[[6]https://eur03.safelinks.protection.outlo...

START FOI request:

Q1. Has the university committed to licensing its medical discoveries in
ways that promote access and affordability in Low- and Middle- Income
Countries? If yes, please provide a link or PDF to the relevant policy
document.

Q2. Please provide an Excel spreadsheet with headings as displayed below
with all the health technologies LICENSED by the university in the period
19th October 2019 to 19th October 2020 AND specify which countries they
were licensed in AND specify whether they are exclusive or non-exclusive
licenses.

Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive)

Q3. Please provide a list of patents granted to your organization in the
period 19th October 2019 to 19th October 2020, listed by patent family,
indicating countries/regions in which the patent has been granted.

Q4. In the period 19th October 2019 to 19th October 2020, has the
university shared its best practices for promoting access to medicines
through non-exclusive licensing by carrying out any of the following
activities?

❏ Contributed sample clauses to the AUTM Global Health Toolkit

❏ Published an article, guidance, or other literature on access licensing
practices

❏ Formally presented on access licensing practices at an academic or
professional event, or at another university

❏ Informally shared or discussed access licensing practices with
administrators at other universities

❏ Other

❏ None

(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in
the period 19th October 2019 to 19th October 2020 to improve access to the
technologies they license in low-and middle-income settings?

END FOI request.

If you have any questions please do not hesitate to contact me by email.

Yours faithfully,

Sarai Keestra

-------------------------------------------------------------------

Please use this email address for all replies to this request:

[FOI #703582 email]

Is [University of Exeter request email] the wrong address for Freedom of
Information requests to University of Exeter? If so, please contact us
using this form:

[7]https://eur03.safelinks.protection.outlo...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[8]https://eur03.safelinks.protection.outlo...

For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:

[9]https://eur03.safelinks.protection.outlo...

Please note that in some cases publication of requests and responses will
be delayed.

If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.

-------------------------------------------------------------------

References

Visible links
2. https://eur03.safelinks.protection.outlo...
3. https://eur03.safelinks.protection.outlo...
4. https://eur03.safelinks.protection.outlo...
5. https://eur03.safelinks.protection.outlo...
6. https://eur03.safelinks.protection.outlo...
7. https://eur03.safelinks.protection.outlo...
8. https://eur03.safelinks.protection.outlo...
9. https://eur03.safelinks.protection.outlo...